AbbVie Shares Drop Amid Missed Sales Expectations for Key Drugs

Text size AbbVie stock is up 15.4% so far this year. Courtesy of AbbVie In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key drugs missed Wall Street estimates. The company’s first-quarter earnings were roughly in line with Wall Street expectations. AbbVie (ticker: ABBV) … Read more

Sierra Oncology Stock Soars After $ 1.9 Billion Takeover by GSK

Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy US rare cancer therapy company Sierra Oncology for $ 1.9 billion in cash, as it looks to boost its portfolio of new specialty medicines. The UK drugmaker will pay … Read more

Investor Bought Up Moderna and Nvidia Stock. It Sold Salesforce and Sirius XM.

Text size A large UK-based asset manager bought up Moderna and Nvidia stock in the fourth quarter. Clement Mahoudeau / AFP via Getty Images A large UK-based asset manager made big changes in its US stock portfolio, buying names that outperformed last year, and selling those that had lackluster showings. Royal London Asset Management significantly … Read more